Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC13616 structure
    GC13616Sodium ascorbate
    CAS: 134-03-2
    纯度: >98.00% / >99.00%

    Sodium ascorbate是一种内源性抗氧化剂,通过参与体内的羟化反应,促进细胞间质形成、辅助合成皮质激素,并通过促进叶酸还原和铁离子吸收来影响血细胞成熟,同时具有抗组胺和阻止亚硝胺生成的作用。

  • GC13628 structure
    GC13628BMS-833923
    CAS: 1059734-66-5
    纯度: >98.00%

    An orally bioavailable Smo inhibitor

  • GC13630 structure
    GC13630MK-4101
    CAS: 935273-79-3
    纯度: >98.00%

    A Smoothened receptor antagonist

  • GC13636 structure
    GC13636BIBR 1532
    CAS: 321674-73-1
    纯度: >99.50%

    BIBR 1532是一种强效的小分子人类端粒酶抑制剂,对端粒酶的抑制作用的IC 50 值为5μM。BIBR 1532会导致端粒缩短并减少肿瘤细胞的增殖。

  • GC13648 structure
    GC13648CC-223
    CAS: 1228013-30-6

    A potent, selective inhibitor of mTOR

  • GC13667 structure
    GC13667Temozolomide
    CAS: 85622-93-1
    纯度: >98.00% / >98.50%

    替莫唑胺是一种口服活性烷化剂,可诱导 DNA 中 O6-甲基鸟嘌呤的形成,其在随后的 DNA 复制周期中与胸腺嘧啶错配,从而激活细胞凋亡途径,替莫唑胺可穿过血脑屏障并适用于恶性神经胶质瘤和转移性黑色素瘤。

  • GC13671 structure
    GC13671Busulfan
    CAS: 55-98-1
    纯度: >98.00% / >97.00%

    Busulfan是一种烷化剂,可通过烷基化作用修饰DNA,对human serum Paraoxonase 1的IC 50 值为77μM。

  • GC13693 structure
    GC13693Omaveloxolone (RTA-408)
    CAS: 1474034-05-3
    纯度: >99.00% / >98.00%

    Omaveloxolone (RTA-408)是一种抗氧化炎症调节剂(AIM),可激活Nrf2并抑制一氧化氮(NO)的生成。

  • GC13697 structure
    GC13697AG-1024
    CAS: 65678-07-1
    纯度: >98.50%

    AG-1024是一种可逆的,竞争性和选择性的胰岛素样生长因子-1受体(IGF-1R)抑制剂,IC 50 值为7μM。AG-1024能够抑制胰岛素受体(IR)的磷酸化,IC 50 值为57μM。

  • GC13706 structure
    GC13706Droxinostat
    CAS: 99873-43-5
    纯度: >99.50%

    An inhibitor of HDAC3, HDAC6, and HDAC8

  • GC13795 structure
    GC13795Isobavachalcone
    CAS: 20784-50-3
    纯度: >98.00%

    A chalcone and flavonoid with diverse biological activities

  • GC13805 structure
    GC13805Abacavir
    CAS: 136470-78-5
    纯度: >99.50%

    阿巴卡韦是一种具有口服活性和竞争性的核苷类逆转录酶抑制剂。

  • GC13835 structure
    GC13835Toremifene Citrate
    CAS: 89778-27-8
    纯度: >99.50%

    A selective estrogen receptor modulator

  • GC13858 structure
    GC13858Torin 2
    CAS: 1223001-51-1
    纯度: >99.50%

    Selective inhibitor of mTOR

  • GC13859 structure
    GC13859Z-DEVD-AFC
    CAS: 1135416-11-3

    A caspase-3 fluorogenic substrate

  • GC13885 structure
    GC13885Elesclomol (STA-4783)
    CAS: 488832-69-5
    纯度: >99.00% / >98.00%

    Elesclomol(也称为 STA-4783)最初是在基于细胞的表型筛选中发现的促凋亡活性,是一种新型小分子,可通过快速产生活性氧 (ROS) 有效诱导癌细胞凋亡以及难以控制的氧化应激水平的诱导。

  • GC13906 structure
    GC13906Nebivolol hydrochloride
    CAS: 152520-56-4
    纯度: >99.50% / >98.00%

    Nebivolol hydrochloride是第三代β1肾上腺素受体选择性拮抗剂,Nebivolol hydrochloride通过高选择性阻断β1受体并激活一氧化氮(NO)介导的血管扩张双重机制发挥降压作用,同时对外周血管阻力、代谢及性功能影响。

  • GC13959 structure
    GC13959Adarotene
    CAS: 496868-77-0
    纯度: >99.00%

    An atypical retinoid

  • GC13968 structure
    GC13968SB202190 (FHPI)
    CAS: 152121-30-7
    纯度: >99.50% / >99.00%

    SB 202190是一种选择性p38 MAP激酶抑制剂,对p38α和p38β2的IC50分别为50 nM和100 nM。

  • GC13984 structure
    GC13984Tamibarotene
    CAS: 94497-51-5
    纯度: >99.50%

    A selective RARα agonist

  • GC13998 structure
    GC13998AT7519 Hydrochloride
    CAS: 902135-91-5
    纯度: >99.00%

    A Cdk inhibitor

  • GC14007 structure
    GC14007DCC-2036 (Rebastinib)
    CAS: 1020172-07-9
    纯度: >99.50%

    An orally bioavailable tyrosine kinase inhibitor

  • GC14016 structure
    GC14016Sulforaphane
    CAS: 4478-93-7
    纯度: >98.00% / >99.00% / >97.00%

    萝卜硫素 (SFN) 称为 [1-isothiocyanato-4-(methylsulfinyl)butane]。

  • GC14022 structure
    GC14022Voreloxin Hydrochloride
    CAS: 175519-16-1
    纯度: >99.50%

    Voreloxin Hydrochloride 是一流的拓扑异构酶 II 抑制剂,可嵌入 DNA 并诱导位点选择性 DNA DSB、G2 停滞和细胞凋亡。